Cancers, Free Full-Text

Control of the immune response is crucial for tumour onset and progression. Tumour cells handle the immune reaction by means of secreted factors and extracellular vesicles (EV). Tumour-derived extracellular vesicles (TEV) play key roles in immune reprogramming by delivering their cargo to different immune cells. Tumour-surrounding tissues also contribute to tumour immune editing and evasion, tumour progression, and drug resistance via locally released TEV. Moreover, the increase in circulating TEV has suggested their underpinning role in tumour dissemination. This review brings together data referring to TEV-driven immune regulation and antitumour immune suppression. Attention was also dedicated to TEV-mediated drug resistance.

A pan-cancer compendium of chromosomal instability

Frontiers Dietary Salt Intake and Gastric Cancer Risk: A Systematic Review and Meta-Analysis

Information and Resources about for Cancer: Breast, Colon, Lung, Prostate, Skin

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Basic Information About Breast Cancer

The autophagic paradox in cancer therapy

Hallmarks of Cancer: The Next Generation: Cell

Breast Cancer Awareness Month - National Breast Cancer Foundation

Zodiac Compatibility: What Signs Are Compatible With Cancer

Pancreatic Cancer Action Network – Research, Patient Support, Resources

Cancer Cells vs. Normal Cells: How Are They Different?

Destination Healthy Skin Toolkit - The Skin Cancer Foundation

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Cervical Cancer: Causes, Symptoms, Diagnosis & Treatment